Ignite Creation Date:
2025-12-24 @ 2:01 PM
Ignite Modification Date:
2026-02-10 @ 1:04 PM
Study NCT ID:
NCT02419495
Status:
TERMINATED
Last Update Posted:
2025-06-04
First Post:
2015-04-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06-26
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-16
Completion Date Type:
ACTUAL
First Submit Date:
2015-04-14
First Submit QC Date:
None
Study First Post Date:
2015-04-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-30
Last Update Post Date:
2025-06-04
Last Update Post Date Type:
ACTUAL